Search Results

Containing any of the words

Only of the type

A Multicenter, Open-label, Single-arm, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST LTE) Drug Clinical Trial

"SFDA" prevent entry of 10.6 million kilograms of food to Saudi Arabia during the last 6 months due to violations Warnings

SFDA Released 9.4 million tons and Rejected 15k tons of Foods in one year News

Two issues related to ParaPAC plus™ Model 300 and Model 310 Ventilator Medical Report

SFDA Monitors 118 Violations During 2,014 Inspection Tours in July News

SFDA Monitors 274 Violations During 4,891 Inspection Tours in August News

SFDA Monitors 291 Violations During 4,677 Inspection Tours in June News

A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST) Drug Clinical Trial

SFDA Monitors More than 500 violations in facilities that did not adhere to COVID-19 precautions during 2021 News

An open-label, controlled, multi-site, Phase 2 clinical trial to assess the ureagenesis capacity in newborns and infants up to the age of 12 months with neonatal and infantile onset of urea cycle disorders (UCD) using a 15N ammonium chloride tracer compared to newborns and infants without UCD Drug Clinical Trial